Steven H Holtzman Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Steven H Holtzman.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Steven H Holtzman. Steven H Holtzman is a EVP Corporate Development in BIOGEN INC. ($IDPH) and a Director in ANADYS PHARMACEUTICALS INC ($ANDS).

Address: C/O ANADYS PHARMACEUTICALS 3115 MERRYFIELD ROW SAN DIEGO 92121 CA

Companies in which Steven H Holtzman is an Insider

ANADYS PHARMACEUTICALS INC

Trading Symbol: ANDS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven H Holtzman: Director
Holdings: 0 shares
Latest Transaction: May 29 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOGEN INC.

Trading Symbol: IDPH
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steven H Holtzman: EVP Corporate Development
Holdings: 8,326 shares
Latest Transaction: Feb 25 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Steven H Holtzman

Sentiment: All, ANDS, IDPH

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 25 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Option ExerciseJ0.001,14903,462
Feb 25 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Option ExerciseM0.0057904,611
Feb 25 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Payment of ExerciseF258.9927370,7048,3268.6 K to 8.3 K (-3.17 %)
Feb 25 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...BuyM0.0057908,5998 K to 8.6 K (+7.22 %)
Feb 17 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Option ExerciseJ0.001,39402,448
Feb 17 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Option ExerciseM0.002,14202,147
Feb 17 2016IDPHBIOGEN INC.Holtzman Steven HEVP Corporate Devel ...Option ExerciseM0.001,05203,842

View all Steven H Holtzman insider transactions.